Table 4 Concentration range of the biomarkers (with median)
From: No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
Biomarker | Median (IQR) | Min - Max |
|---|---|---|
Aβ38 MSD (pg/mL) | 990.9 (440.1–1396.0) | 33.3–2573.0 |
Aβ40 MSD (pg/mL) | 2514.9 (1154.8–3356.5) | 79.3–5880.5 |
Aβ42 MSD (pg/mL) | 182.1 (54.1–266.6) | 5.5–921.2 |
Aβ38 Euroimmun (pg/mL) | 1247.7 (1120.9–1462.0) | 277.5–2492.5 |
Aβ40 Euroimmun (pg/mL) | 4669.0 (3605.0–5305.0) | 1487.0–9382.2 |
Aβ42 Euroimmun (pg/mL) | 337.9 (191.9–521.8) | 70.6–1253.4 |
t-tau Euroimmun (pg/mL) | 464.7 (223.0–917.6) | 29.3–1501.0 |
Aβ42 Fujirebio (pg/mL) | 568.0 (294.5–786.0) | 91.0–1507.0 |
t-tau Fujirebio (pg/mL) | 319.0 (180.2–742.2) | 72.0–1832.0 |
p-tau (pg/mL) | 43.0 (30.3–52.8) | 15.0–113.0 |
sAPPα (ng/mL) | 60.4 (32.5–178.8) | 4.3–429.6 |
sAPPβ (ng/mL) | 66.4 (25.5–175.0) | 1.4–313.6 |
YKL-40 (ng/mL) | 264.6 (151.9–348.4) | 65.4–1020.0 |
VILIP-1 (pg/mL) | 113.5 (99.0–135.0) | 72.0–781.0 |
Neurogranin (pg/mL) | 354.5 (275.9–435.4) | 46.3–1291.1 |
ApoE (ng/mL) | 24.5 (18.8–44.4) | 3.4–104.2 |